Sfoglia per AUTORE
LENOCI D
Collezione AO Cuneo
Items : 1
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer. in Cells / Cells. 2022 Oct 10;11(19):3176. doi: 10.3390/cells11193176.
2022
AO Cuneo
AOU Novara
AO Cuneo
AOU Novara
De Cecco L; Licitra L; Bossi P; Ferraù F; Rinaldi G; Vaccher E; Moretti G; Denaro N; Caponigro F; Rocca MC; Secondino S; Moro C; Sponghini A; Caldara A; Ferrari D; Vecchio S; Lenoci D; Pistore F; Miceli R; Canevari S; Cavalieri S; Carenzo A; Serafini MS;